Riskpilot← Back to searchSign inGet full accessABBOTT LABORATORIES A/S
A/SActiveCVR 31528615Arne Jacobsens Allé 13, 2.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 197147 employees
Revenue 2024
DKK 350,4M
+7% vs 2023
EBITDA margin
4.4%
+3% vs 2023
Equity ratio
53.8%
Financial strength
Net profit 2024
DKK 8,3M
-10% vs 2023
| Revenue | DKK 350,4M | +7% |
| EBITDA | DKK 15,4M | +3% |
| Net profit | DKK 8,3M | -10% |
| Total assets | DKK 262,6M | +20% |
| Equity | DKK 141,2M | +6% |
| Employees | 47 | — |
Legal name
ABBOTT LABORATORIES A/S
CVR number
31528615
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4. februar 1971
Share capital
DKK 4.026.000
Employees
47 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af den samlede
bestyrelse.
Company purpose
Selskabets formål er at drive handel med farmaceutiske produkter, kemiske produkter, hospitalsprodukter og diagnostik samt udvikle, producere og markedsføre teknologi og know-how i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser eller assistance, herunder af administrativ, driftsmæssig, finansiel, forretningsmæssig, videnskabelig eller industriel karakter, i tilknytning til Selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selskaber.
Address
Arne Jacobsens Allé 13, 2.
Phone
+4539770000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 173.166 | 149.805 | 140.659 | 133.978 | 147.370 | 128.992 | 162.924 | 195.944 | 259.193 | 268.116 | 327.404 | 350.377 |
| Staff expenses | -31.714 | -29.520 | -28.847 | -32.743 | -25.453 | -24.654 | -30.840 | -31.882 | -35.257 | -42.144 | -47.713 | -48.174 |
| EBITDA | 8.150 | 21.740 | 15.098 | 6.073 | 8.944 | -2.152 | 8.937 | 7.864 | 8.902 | 9.038 | 14.885 | 15.390 |
| Depreciation & amort. | -2.875 | -1.262 | -1.310 | -1.326 | -1.121 | -831 | -1.102 | -1.710 | -1.209 | -995 | -1.556 | -2.125 |
| EBIT | 5.274 | 20.479 | 13.788 | 4.747 | 7.823 | -2.983 | 7.834 | 6.153 | 7.694 | 8.043 | 13.330 | 13.264 |
| Net financials | 138 | 59 | 301 | 111 | 263 | -2 | -32 | 136 | -16 | -61 | -1.622 | -2.228 |
| Profit before tax | 5.412 | 20.538 | 14.090 | 4.858 | 8.085 | -2.985 | 7.802 | 6.289 | 7.678 | 7.983 | 11.707 | 11.036 |
| Tax | 2.200 | 5.446 | 3.622 | 1.544 | 2.379 | -857 | 1.762 | 1.465 | 1.704 | 1.884 | 2.539 | 2.760 |
| Net profit | 3.211 | 15.091 | 10.467 | 3.314 | 5.706 | -2.128 | 6.040 | 4.825 | 5.974 | 6.098 | 9.168 | 8.276 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 51.563 | 62.670 | 74.454 | 77.382 | 82.679 | 187.175 | 178.470 | 164.580 | 183.202 | 207.593 | 218.289 | 262.577 |
| Equity | 24.290 | 39.381 | 49.849 | 53.163 | 58.869 | 150.850 | 106.890 | 111.715 | 117.689 | 123.788 | 132.956 | 141.232 |
| Long-term debt | 3.397 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.363 |
| Short-term debt | 25.042 | 22.992 | 24.605 | 24.209 | 23.810 | 35.701 | 70.974 | 52.205 | 63.647 | 82.039 | 83.216 | 117.981 |
| Total debt | 25.042 | 22.992 | 24.605 | 24.209 | 23.810 | 35.701 | 70.974 | 52.205 | 63.647 | 82.039 | 83.216 | 121.345 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20132024
Equity ratio
53.8%
This company
38.2%
Market median
+41% vs market
20132024
Return on equity
5.9%
This company
18.4%
Market median
-68% vs market
20132024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
20132024
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
20132024
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AJ Management | Management | 1971 | — | — |
OM Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Audit | 1971 | — | — | |
HA | Management | 1998 | — | — |
IB Management | Management | 1971 | — | — |
AW Management | Management | 2007 | — | — |
KA Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
MF Management | Management | 1971 | — | — |
PM Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
PF Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
JP Management | Management | 2002 | — | — |
CØ Management | Management | 1971 | — | — |
CD Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
OI Management | Management | 1971 | — | — |
LV Management | Management | 2006 | — | — |
JK Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
EH Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
LR Chief Executive Officer | Chief Executive Officer | 1971 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2002 | — | — | |
| Chairman | 1971 | — | — | |
| Chairman | 2016 | — | — | |
| Chairman | 1971 | — | — | |
| Board of Directors | 1971 | — | — | |
| Board of Directors | 1971 | — | — | |
| Chairman | 1971 | — | — | |
| Board of Directors | 1971 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 1971 | — | — | |
| Board of Directors | 2013 | — | — | |
| Chairman | 1971 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 1971 | — | — | |
| Board of Directors | 2008 | — | — | |
| Chairman | 2019 | — | — | |
| Chairman | 1971 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2023 | |
| Individual | 100.0% | 100.0% | 2012 | |
| Individual | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ABBOTT LABORATORIES A/S 
Abbott Medical Danmark A/SBoard members of ABBOTT LABORATORIES A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arthur Joseph Higgins | Management | 0 companies |
| Ole Martin Alfstad Christiansen | Chief Executive Officer | 0 companies |
| ANDERSEN STATSAUTORISERET REVISIONSAKTIESELSKAB | Audit | 0 companies |
| Henricus Adrianus Maria Lambertus van de Laar | Management | 0 companies |
| Ian Black | Management | 0 companies |
| Alexander Würfel | Management | 0 companies |
| Karl Andreas Almroth | Chief Executive Officer | 0 companies |
| Mark Francis Gorman | Management | 0 companies |
| Palle Michael Christensen | Chief Executive Officer | 0 companies |
| Peter Frønsdal Toft | Chief Executive Officer | 0 companies |
| Jean Paul Kress | Management | 0 companies |
| Christer Øhlund | Management | 0 companies |
| Christina Dyreborg Jeppesen | Chief Executive Officer | 0 companies |
| Odd Inge Vaage-Nilsen | Management | 0 companies |
| Laurent Van Lerberghe | Management | 0 companies |
| Jorun Klokk Holst | Chief Executive Officer | 0 companies |
| Erik Hjalmar Björkman | Chief Executive Officer | 0 companies |
| Leif Ramtung | Chief Executive Officer | 0 companies |
| Thomas Craig Freyman | Chairman | 0 companies |
| Siegfried Brune | Chairman | 0 companies |
| Brian B. Yoor | Chairman | 0 companies |
| John Afseth | Chairman | 0 companies |
| Mark Collier Miller | Board of Directors | 0 companies |
| Jan-Erik Collin | Board of Directors | 0 companies |
| Alain Joseph Marie Gilbert | Chairman | 0 companies |
| Jonh Duncan McIntyre | Board of Directors | 0 companies |
| Kate Tørnø | Board of Directors | 0 companies |
| Robert Leory Parkinson, jr | Board of Directors | 0 companies |
| Fredrik Björn Anders Björnulfson | Board of Directors | 0 companies |
| Thomas Richard Hodgson | Chairman | 0 companies |
| Bradley Jay Slater | Chairman | 0 companies |
| Gary Patrick Coughlan | Chairman | 0 companies |
| Tom Schjødt | Board of Directors | 0 companies |
| Benjamin Edward Oosterbaan | Chairman | 0 companies |
| Ørn Reidar Stuge | Chairman | 0 companies |